Osome
PrivateLast Round
Series B
Extension
May 17, 2024
Est. Valuation
$56.87M
Total Funding Raised
$66M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Osome operates in FinTech and is based in Singapore. Its latest recorded funding round was a Series B Extension round in May 2024.
Osome is a fintech company that provides an AI-enabled business management platform for automating administrative services including accounting, bookkeeping, company incorporation, and tax filing for small and medium-sized enterprises.
Sector
FinTech
Verticals
Accounting & Expense, Compliance, Workflow Automation, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Osome Comparables
Compare Osome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sleek | 93% | |
| Lanturn | 86% | |
| Crunch | 79% |
For institutional investors. Book with your work email.
Osome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 17, 2024 | ||||
| Series B | Dec 6, 2022 | ||||
| Series A | Jun 10, 2021 | ||||
| Seed | Nov 5, 2020 | ||||
| Seed | Nov 26, 2019 | ||||
Seed | Dec 11, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Osome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pagil | Series A |
| Adru Tech | Series A |
| Digital Direction Singapore Services | Series A |
| Winter Capital | Series B |
| HS Investments | Series A |
| Constructor Capital | Series B Extension |
| AdFirst | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Supported over 50,000 companies.
- Apr 27, 2026
Serves thousands of businesses according to a job posting.
For institutional investors. Book with your work email.
Osome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Osome's valuation, stock price, and market status.
Is Osome a public or private company?
Osome is a private company.
What is the current stock price of Osome?
Osome is a private company, so its shares have no public market price. Caplight tracks Osome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Osome worth (valuation)?
Osome's valuation is estimated at $56.9M based on funding round data.
Can I buy Osome stock?
Osome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Osome's last funding round?
Osome's most recent funding round was Series B Extension on May 17, 2024.
Who are the main investors in Osome?
Key investors in Osome include Constructor Capital, Target Global, AltaIR Capital, Rockstone Ventures, XA Network.
Will Osome IPO soon?
No public IPO plans have been announced for Osome.
How can I track Osome secondary market activity?
Caplight tracks bids, offers, and trades in Osome's shares on secondary markets.